Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), Product (Repair Products, Mitral Valve Repair Devices, and Tricuspid Valve Repair Devices), Technology (Biological valve and Decellularized valve) End Use (Hospitals, Ambulatory Surgical Centres, Speciality Clinics, and Others) – Industry Trends and Forecast to 2031
.
The Global Prosthetic Heart Valve Market size was valued at USD 6.96 USD Billion in 2023.
The Global Prosthetic Heart Valve Market is projected to grow at a CAGR of 9.79% during the forecast period of 2024 to 2031.
The major players operating in the market include Abbott, Medtronic, Medical Technology Est., Boston Scientific Corporation, Micro Interventional Devices, Inc., Medical Circle, Edwards Lifesciences Corporation, LivaNova PLC., JenaValve Technology, Inc., Cryolife, Inc.,TTK HealthCare, JenaValve Technology, Inc., LivaNova PLC, Lepu Medical Technology (Beijing) Co., Ltd.., Braile Biomédica, SYMETIS, Labcor Laboratórios Ltda., JenaValve, LEPU MEDICAL TECHNOLOGY, Braile Biomédica, Colibri Heart Valve, Cardiac Dimensions Inc., Cardiosolutions,Leman Cardiovascular, Medtentia AB, MitralSolutions, Inc., On-X Life Technologies, Inc., Sadra Medical, Inc., Sorin S.p.A., St. Jude Medical, Inc. and ValveXchange.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
